Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03250078 · ClinicalTrials.gov registry record
A Pancreatic Cancer Screening Study in Hereditary High Risk Individuals
A clinical trial of Pancreatic Neoplasms, sponsored by Nuvance Health.
- Recruiting
- Registry status
- 200
- Enrollment target
- 1
- Study location
NCT03250078: Recruiting study of Pancreatic Neoplasms, sponsored by Nuvance Health.
NCT03250078 is a study of Pancreatic Neoplasms that is actively recruiting participants, run by Nuvance Health. The registered enrollment target is 200 participants, below the 595-participant average among 30 other Pancreatic Neoplasms trials with a reported enrollment target (66% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03250078, a study of Pancreatic Neoplasms, is actively recruiting participants, sponsored by Nuvance Health.
- RECRUITING
- Registry status
- 200 participants
- Enrollment target
- 1
- Study location
Study Summary
The main goal of this study is to screen and detect pancreatic cancer and precursor lesions in individuals with a strong family history or genetic predisposition to pancreatic cancer. Magnetic Resonance Imaging and Magnetic cholangiopancreatography (MRI/MRCP) will be utilized to screen for early stage pancreatic cancer or precursor lesions. Participants will be asked to donate a blood sample at specific intervals for the creation of a bio-bank necessary for the development of a blood based screening test for Pancreatic Cancer.
Primary Outcome
Incidence of Pancreatic Cancer or precursor lesions within a population of individuals with a strong family history of pancreatic cancer or known genetic mutation compared to the expected incidence in the general population.
Conditions Studied
Interventions
- DIAGNOSTIC_TEST MRI/MRCP
Study Locations (1)
Connecticut
- Nuvance Health - Norwalk
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2016-11 |
| Est. Completion | 2026-11 |
What NCT03250078 shows while recruiting
NCT03250078 is an observational study that tracks outcomes without assigning an intervention. The registered 200 participants enrollment target is mid-sized for trials with a published cap, below the 595-participant average among 30 other Pancreatic Neoplasms trials with a reported enrollment target (66% lower).
The record links to 1 condition, with Pancreatic Neoplasms appearing as the primary indexed condition, and to 1 intervention - of which MRI/MRCP is the first listed.
NCT03250078 reports a single indexed study location in Connecticut.
Frequently Asked Questions
What is clinical trial NCT03250078 about?
NCT03250078 is a clinical study titled "A Pancreatic Cancer Screening Study in Hereditary High Risk Individuals". The main goal of this study is to screen and detect pancreatic cancer and precursor lesions in individuals with a strong family history or genetic predisposition to pancreatic cancer. Magnetic Resonance Imaging and Magnetic cholangiopancreatography (MRI/MRCP) will be utilized to screen for early sta...
What is the current status of trial NCT03250078?
This trial is currently recruiting. The enrollment target is 200 participants. The study started on 2016-11. Estimated completion is 2026-11.
What conditions does trial NCT03250078 study?
This clinical trial studies the following conditions: Pancreatic Neoplasms.
What interventions are being tested in trial NCT03250078?
The interventions under investigation include: MRI/MRCP (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT03250078?
This trial is sponsored by Nuvance Health, which has 4 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03250078 being conducted?
This trial has 1 study location across Connecticut. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pancreatic Neoplasms
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03250078's enrollment target sits among peer trials
200 11th of 30 higher than 19 of 30 other Pancreatic Neoplasms trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Pancreatic Neoplasms trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
A Pancreatic Cancer Screening Study in Individuals With New-Onset or Deteriorating Diabetes Mellitus
RECRUITING
-
Determining Individualized Cancer Therapy in Pancreatic Cancer
RECRUITING
-
Tumor Subtypes in Subjects on FOLFIRINOX With Non-Metastatic Pancreatic Cancer
RECRUITING · Phase 2
-
Tissue Procurement and Natural History Study of Patients With Malignant Mesothelioma
RECRUITING
-
The Role of MicroRNA in the Diagnosis, Prognosis and Response to Treatment in Pancreatic Cancer
RECRUITING
-
UCSF PANC Cyst Registry
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00107289 · 200 participants · Phase 2
Iodine I 131 Metaiodobenzylguanidine in Treating Patients With Recurrent, Progressive, or Refractory Neuroblastoma or Malignant Pheochromocytoma or Paraganglioma
- NCT00109174 · 200 participants · NA
MRS Measurement of Glutamate and GABA Metabolism in Brain
- NCT00177268 · 200 participants
Blood, Urine, and Tissue Collection for Cutaneous Lymphoma, Eczema, and Atopic Dermatitis Research
- NCT00493688 · 200 participants
A Study to Determine Whether Perioperative Energy Dynamics Correlates With Postoperative Outcomes
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia